Early arthritis clinics: If you build it will they come?

Journal of Rheumatology

Volumn 32, Issue 2, 2005, Pages 203-207

  Cush, John J ^a,b,c  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; RHEUMATOID FACTOR;

ARTHRITIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE DURATION; EDITORIAL; HUMAN; MEDICAL RESEARCH; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SEROLOGY;

ALGORITHMS; AMBULATORY CARE FACILITIES; ARTHRITIS, RHEUMATOID; EARLY DIAGNOSIS; HUMANS; RHEUMATOLOGY;

EID: 13444278541     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (37)

1. Chan KW, Felson DT, Yood RA, Walker AM. The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum 1994;37:814-20.
2. Hernandez-Garcia C, Vargas E, Abasolo L, et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000;27:2323-8.
3. Irvine S, Munro R, Porter D. Early referral, diagnosis, and treatment of rheumatoid arthritis: evidence for changing medical practice. Ann Rheum Dis 1999;58:510-3.
4. Feinglass J, Nelson C, Lawthier T, Chang RW. Chronic joint symptoms and prior arthritis diagnosis in community surveys: Implication for arthritis prevalence estimates. Public Health Rep 2003;118:230-9.
5. Rat AC, Henegariu V, Boissier MC. Do primary care physicians have a place in the management of rheumatoid arthritis? Joint Bone Spine 2004;71:190-7.
6. Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
7. Raza K, Breeze M, Nightingale P, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 2005;32:231-8.
8. Sokka T, Willoughby J, Yazici Y, Pincus T. Databases of patients with early rheumatoid arthritis in the USA. Clin Exp Rheumatol 2003;21 Suppl 31:S146-53.
9. Cush JJ. Early arthritis clinic: A USA perspective. Clin Exp Rheumatol 2003;21 Suppl 31:S75-8.
10. Aletaha D, Eberl G, Nell VPK, Machold KP, Smolen JS. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 2002;61:630-4.
11. Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. New Engl J Med 2000;343:1586-93.
12. Smolen J, van der Heijde D, Emery P, et al. Infliximab inhibits radiographic joint damage in patients with early rheumatoid arthritis regardless of clinical response after 54 week treatment [abstract]. Ann Rheum Dis 2004;63 Suppl I:260.
13. Breedveld FC, Kavanaugh AF, Cohen SB, et al. Early treatment of rheumatoid arthritis (RA) with adalimumab (Humira®) plus methotrexate vs. Adalimumab alone or methotrexate alone: The PREMIER Study [abstract]. Arthritis Rheum 2004;50 Suppl:L5.
14. Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989;16:585-91.
15. McQueen FM, Benton N, Perry D, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
16. Wolfe F, Ross K, Hawley F, et al. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 1993;20:2005-9.
17. Green MJ, Marzo-Ortega H, McGonagle D, et al. Persistence of mild early inflammatory arthritis: the importance of disease duration, rheumatoid factor and shared epitope. Arthritis Rheum 1999;42:2184-8.
18. Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002;61:700-3.
19. Saraux A, Berthelot JM, Chales G, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001;44:2485-91.
20. van der Horst-Bruinsma IE, Speyer I, Visser H, Breedveld FC, Hazes JM. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 1998;37:1084-8.
21. Wiik AS, van Venrooij WS. The use of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA. American College of Rheumatology Hotline. October 2003. [Internet] [cited December 11, 2004]. Available from http://www. rheumatology.org/publications/hotline/1003anticcp.asp?aud=mem
22. Rantapaa-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
23. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003;171:538-41.
24. Van Jaarsveld CHM, ter Borg EJ, Jacobs JW, et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999;17:689-97.
25. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration. Arthritis Rheum 2000;43:22-9.
26. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology Oxford 2004;43:906-14.
27. Landewe RB, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002;42:347-56.
28. Mottonen T, Hannonen P, Korpela M, et al. Delay to institution of therapy and induction of remission using single-drug or combination disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8.
29. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
30. van Aken J, Lard LR, le Cessie S, Hazes JM, Breedveld FC, Huizinga TW. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004;63:274-9.
31. Verstappen SM, Jacobs JW, Bijlsma JW; Utrecht Rheumatoid Arthritis Cohort Study Group. The Utrecht experience with different treatment strategies in early rheumatoid arthritis. Clin Exp Rheumatol 2003;21 Suppl 31:S165-8.
32. Tsakonas E, Fitzgerald AA, Fitzcharles MA, et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000;27:623-9.
33. Wolfe K, Cush JJ, O'Dell JR, et al. Consensus recommendations for the assessment and treatment of rheumatoid arthritis. J Rheumatol 2001;28:1423-30.
34. Pincus T, Gibofsky A, Weinblatt ME. Urgent care and tight control of rheumatoid arthritis as in diabetes and hypertension: better treatments but a shortage of rheumatologists. Arthritis Rheum 2002;46:851-4.
35. Newman ED, Harrington TM, Olenginski TP, Perruquet JL, McKinley K. "The rheumatologist can see you now": Successful implementation of an advanced access model in a rheumatology practice. Arthritis Rheum 2004;51:253-7.
36. Lipsky PE, Alarcon GS, Bombardier C, et al. Algorithms for the diagnosis and management of musculoskeletal complaints. Am J Med 1997;103:49S-85S.
37. Gormley GJ, Steele WK, Gilliland A, et al. Can diagnostic triage by general practitioners or rheumatology nurses improve the positive predictive value of referrals to early arthritis clinics? Rheumatology Oxford 2003;42:763-8.